Detalles de la búsqueda
1.
Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide.
Eur J Clin Invest;
54(4): e14147, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071418
2.
Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients.
Am J Nephrol;
53(6): 470-480, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613556
3.
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
Gastroenterology;
157(2): 481-491.e7, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31022403
4.
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series.
J Antimicrob Chemother;
75(9): 2666-2669, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32437580
5.
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.
JAMA;
320(19): 2010-2019, 2018 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30422235
6.
The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney Disease.
Am J Nephrol;
46(3): 239-248, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881341
7.
Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.
Graefes Arch Clin Exp Ophthalmol;
255(12): 2443-2449, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063192
8.
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.
Am J Kidney Dis;
63(3): 446-55, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24342522
9.
Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.
Mol Cell Proteomics;
11(4): M111.014563, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22184099
10.
Severe Hyponatremia After Drinking Horsetail Juice.
Ann Intern Med;
169(7): 507-508, 2018 10 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29809246
11.
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial.
BMJ Open;
12(9): e061339, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130755
12.
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.
Rheumatol Adv Pract;
6(2): rkac045, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35784016
13.
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
Trials;
23(1): 939, 2022 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371234
14.
The rugger-jersey spine.
Kidney Int;
90(2): 454, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418097
15.
Inconvenience due to travelers' diarrhea: a prospective follow-up study.
BMC Infect Dis;
11: 322, 2011 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22099542
16.
Single antigen testing to reduce early antibody-mediated rejection risk in female recipients of a spousal donor kidney.
Transpl Immunol;
67: 101407, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33975014
17.
The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery.
Sci Rep;
11(1): 1071, 2021 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33441876
18.
Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the Netherlands.
Kidney Int Rep;
6(10): 2671-2678, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34622106
19.
Health risks encountered by Dutch medical students during an elective in the tropics and the quality and comprehensiveness of pre-and post-travel care.
BMC Med Educ;
10: 89, 2010 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21126347
20.
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.
PLoS One;
15(5): e0233213, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32442208